AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore

British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.

AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.